FindMyRecallSubscribe
Class III: unlikely to cause harmOngoing

Dr. Reddy's Laboratories Sirolimus Tablets 1mg Tablets 100-count Recall

Sirolimus Tablets 1mg Tablets 100-count bottle, Rx Only, Distributed by: Dr

Dr. Reddy's Laboratories, Inc. · Princeton, NJ

Risk level
Class III
Reported by FDA
May 29, 2024
Recall ID
D-0504-2024
Check your lot numberHow we source this data

Summary

Dr. Reddy's Laboratories recalled Sirolimus Tablets 1mg Tablets 100-count starting May 1, 2024. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-0504-2024 on May 29, 2024. Reason: Failed Impurities/Degradation Specifications. Status: Ongoing.

Why it was recalled

Failed Impurities/Degradation Specifications

Product description

Sirolimus Tablets 1mg Tablets 100-count bottle, Rx Only, Distributed by: Dr. Reddy's Laboratories Inc., Princeton, NJ 08540, Made in India, NDC 55111-653-01

Lot numbers, UPCs & expiration codes

Lot H2200493; Exp 6/30/2025

Where it was sold

US Nationwide.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0504-2024
Classification
Class III
Status
Ongoing
Recall initiated
May 1, 2024
FDA report date
May 29, 2024
Quantity
1,176 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Dr. Reddy's Laboratories, Inc.

Original FDA data

Every field from FDA enforcement report D-0504-2024, exactly as published.

Show all FDA fields
City
Princeton
State
NJ
Status
Ongoing
Country
United States
Event ID
94535
Address
107 College Rd E
Code information
Lot H2200493; Exp 6/30/2025
Postal code
08540-6623
Report date
May 29, 2024
Product type
Drugs
Recall number
D-0504-2024
Classification
Class III
Recalling firm
Dr. Reddy's Laboratories, Inc.
Product quantity
1,176 bottles
Reason for recall
Failed Impurities/Degradation Specifications
Voluntary / mandated
Voluntary: Firm initiated
Product description
Sirolimus Tablets 1mg Tablets 100-count bottle, Rx Only, Distributed by: Dr. Reddy's Laboratories Inc., Princeton, NJ 08540, Made in India, NDC 55111-653-01
Distribution pattern
US Nationwide.
Recall initiation date
May 1, 2024
Center classification date
May 21, 2024

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0504-2024, published May 29, 2024. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls